Drug
Avi 6003
Avi 6003: highest development phase Phase 1, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVI-6003 NCT01353040 | Phase 1 | Marburg Hemorrhagic Fever |
Latest
No recent events.
Follow Avi 6003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.